Phion Therapeutics
PHion Therapeutics is a UK-based biotech delivering groundbreaking nucleic acid vaccines and therapeutics using a proprietary RALA peptide-based drug delivery system for multiple anionic molecules, such.
Financials
Estimates*
| EUR | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | <1m | <1m | <1m |
| % growth | - | 98 % | 43 % |
| EBITDA | (1.3m) | - | - |
| % EBITDA margin | (6836 %) | - | - |
| Profit | (1.1m) | - | - |
| % profit margin | (5774 %) | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
| N/A | £332k | Grant | |
| N/A | £512k | Grant | |
£940k | Grant | ||
£500k | Grant | ||
* | N/A | Early VC | |
| Total Funding | €2.7m | ||
Recent News about Phion Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.